Whitehawk Therapeutics (WHWK) Depreciation & Amortization (CF) (2016 - 2026)
Whitehawk Therapeutics' (WHWK) quarterly Depreciation & Amortization (CF) came in at $1000.0 in Q1 2026, down 98.25% year-on-year from $57000.0 in Q1 2025, and down 95.45% on a QoQ basis from $22000.0 in Q4 2025.
Whitehawk Therapeutics (WHWK) Depreciation & Amortization (CF) (2016 - 2026) Analysis & Trends
Whitehawk Therapeutics (WHWK) has 11 years of Depreciation & Amortization (CF) data on file, last reported at $1000.0 in Q1 2026.
- On a quarterly basis, Depreciation & Amortization (CF) fell 98.25% year-over-year to $1000.0 in Q1 2026; TTM through Mar 2026 was $43900.0, a 82.67% decrease from a year earlier, with the FY2025 full-year figure at $79000.0, down 59.07% from the prior year.
- Depreciation & Amortization (CF) for Q1 2026 stood at $1000.0, down from $22000.0 in the prior quarter.
- Over the last five years, Depreciation & Amortization (CF) for WHWK reached as high as $100000.0 in Q4 2024 and fell as low as $1000.0 in Q1 2026.
- Historically, Depreciation & Amortization (CF) has averaged $39717.6 across 5 years, with a median of $44000.0 in 2023.
- Across the five-year window, Depreciation & Amortization (CF) soared 3600.0% in 2022 and slumped 98.25% in 2026, its largest moves.
- Year by year, Depreciation & Amortization (CF) stood at $46000.0 in 2022, then decreased by 4.35% to $44000.0 in 2023, then jumped by 127.27% to $100000.0 in 2024, then tumbled by 78.0% to $22000.0 in 2025, then plunged by 95.45% to $1000.0 in 2026.
- Per Business Quant data, the three most recent Depreciation & Amortization (CF) figures were $1000.0 in Q1 2026, $22000.0 in Q4 2025, and $5600.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 196,658.72 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 41.14 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 91,781.47 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 55.90 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 123.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 2.20 Mn |
| 10 | Whitehawk Therapeutics | 34.18 Mn | 34.18 Mn | - | 1,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,000.00 |
| Mar 31, 2026 | 1,000.00 |
| Dec 31, 2025 | 22,000.00 |
| Dec 31, 2025 | 22,000.00 |
| Sep 30, 2025 | 5,600.00 |
| Sep 30, 2025 | 5,600.00 |
| Jun 30, 2025 | 15,300.00 |
| Jun 30, 2025 | 15,300.00 |
| Mar 31, 2025 | 57,000.00 |
| Mar 31, 2025 | 57,000.00 |
| Dec 31, 2024 | 100,000.00 |
| Dec 31, 2024 | 100,000.00 |
| Sep 30, 2024 | 46,700.00 |
| Sep 30, 2024 | 46,700.00 |
| Jun 30, 2024 | 49,600.00 |
| Jun 30, 2024 | 49,600.00 |
| Mar 31, 2024 | 50,000.00 |
| Mar 31, 2024 | 50,000.00 |
| Dec 31, 2023 | 44,000.00 |
| Dec 31, 2023 | 44,000.00 |